StockClub
HRTXHeron Therapeutics, Inc.$ --
Heron Therapeutics, Inc.

Heron Therapeutics, Inc.

HRTX

$ -

-

You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.

account_balanceBalance Sheet (BS) Summary

2025/12 Filed: 2026-02-26

Total Assets

account_balance
255.9M USD
No comparison

Shareholders' Equity

savings
14.3M USD
No comparison

Equity Ratio

pie_chart
5.6%
No comparison

Book Value Per Share

paid
0.09USD
No comparison

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %
86420
2021
2022
2023
2024
2025

Balance Sheet Details

Item
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
28.65M
28.65M
17.98M
89.59M
92.75M
9.10M
238.07M
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
0
0
12.40M
12.40M
0
0
5.41M
255.88M
17.81M
255.88M
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
8.99M
0
0
0
8.61M
96.10M
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
140.64M
140.64M
0
4.81M
111.99M
145.45M
241.54M
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
1.88M
166.71M
1.95B
-1.94B
4,000
0
0
14.33M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.